Venari Minerals NL (ASX:VMS) has reported another set of assay results from its October RC drilling program at the Red Mountain Lithium Project in Nevada, describing them as “outstanding”. The latest four drill holes delivered multiple thick, high-grade lithium zones and complete the full drilling dataset for the project’s central zone, paving the way for next month’s maiden Mineral Resource Estimate. Executive Director and CEO Matt Healy joins The Stock Network’s Lel Smits to discuss how these results strengthen Red Mountain’s scale potential and set up a catalyst-rich finish to the year.

⚒️ Thick, high-grade lithium across the central zone
🚀 Complete dataset ahead of the maiden Resource

Sea Forest has listed on the ASX with a ticker code of SEA. The company is an environmental technology business producing climate-change abating products for the agriculture industry. Its flagship SeaFeed supplement replicates the bio-actives found in Asparagopsis - a seaweed native to Australia - to reduce methane production and improve productivity in livestock farming.

Media: The Stock Network @lelsmits

Pengana Private Equity Trust (ASX:PE1) gives investors rare access to global private markets through a single listed vehicle. Managed by Grosvenor Capital Management L.P., one of the world’s longest-operating alternative investment allocators, Pengana Private Equity Trust offers diversified exposure to private equity, private credit and opportunistic investments. Joining The Stock Network’s Lel Smits, Executive Director Adam Myers explains how Pengana Private Equity Trust opens the door to global private companies and long-term growth opportunities.

🌎 Accessing global private markets
🚀 Diversification across global private companies
💡 Listed structure, long-term value and outlook

Blackpearl Group Limited has listed on the ASX with a ticker code of BPG. The company is a data technology business pioneering AI-driven sales marketing solutions for the American market. It specialises in data-driven cloud services, with its suite of standalone products designed to help small and medium-sized businesses drive growth. More than 1,200 companies across the US already use Black Pearl’s products.

Media: The Stock Network @lelsmits

Fertility is a big topic and this fertility treatment company has had some big stock swings this year. Shares in Monash IVF (ASX:MVF) closed more than 40% higher as it confirmed it’s received, and rejected, a takeover bid. The takeover offer was from a major investment consortium, led by private equity firm Genesis Capital and Soul Patts. While they offered $0.80 per share, Monash IVF says this materially undervalues the company. The Consortium already holds ~19.6% of Monash IVF, but the Board has rejected the proposal. The bid comes after a year of scandals for Monash IVF including embryo mix-ups which send the stock falling.

#finktok #finance #health #stocks #money

Have you noticed everyone seems to be getting into matcha? Well you`re not alone. OMG Group (ASX:OMG) has landed its first Australian purchase order for premium Japanese matcha after inking a five-year supply deal with SANDAI. SANDAI is a Japan based matcha manufacturer and the $16,000 order came straight after product trials. The deal opens a new high-margin revenue channel as OMG becomes SANDAI’s exclusive Australian distributor of ceremonial-grade matcha. First container shipments begin January 2026 and OMG says more wholesale enquiries already coming in.

#fintok #stocks #money #matcha #food

Venari Minerals NL (ASX:VMS) has delivered thick, high-grade lithium intersections from the first two holes of its October RC drilling campaign at the Red Mountain Lithium Project in Nevada. With US laboratory congestion now easing, these initial assays mark the beginning of a catalyst-rich period that will see results from 19 drill holes across Red Mountain and Needles arrive over the coming weeks. Executive Director and CEO Matt Healy joins The Stock Network’s Lel Smits to discuss how these results advance Red Mountain toward its maiden Mineral Resource Estimate in December.

⚒️ Thick, high-grade intersections built on previous momentum
⛏️ Confirming continuity ahead of the maiden Mineral Resource Estimate

Bioxyne Limited (ASX:BXN) has secured ~A$1.7 million in funding through its UK subsidiary Breathe Life Sciences (BLSUK) from South of Scotland Enterprise to establish a new GMP medicinal cannabis manufacturing and distribution facility in the Scottish Borders

🏭 The package includes a circa A$1 million five-year loan and a circa A$700,000 grant, supporting the fit-out of a site equivalent in size to Bioxyne’s Australian facility
🌱 Breathe Life Sciences UK aims to become a major UK provider of medicinal cannabis manufacturing and distribution, with licensing applications and full fit-out expected in 2026
📊The UK is Europe’s second-largest medicinal cannabis market, with patients spending an estimated ~A$6,500 annually, more than double Germany’s average

“Existing manufacturing infrastructure in UK is insufficient to keep up with local demand, and that’s an opportunity for BLSUK to enter and grow with the market. BLSUK has a growing UK customer base, establishing our UK facility is critical to offering clients our renowned quality and service levels, and replicating our Australian success internationally.” – Sam Watson, CEO of Bioxyne Limited

“We are delighted to welcome BLSUK, a key international life sciences company, to our region. The South of Scotland has witnessed inward investment enquiries increase by over 450%, with a surge in innovative life sciences and energy companies. The arrival of BLSUK is further confirmation that our region is the place to do innovative business.” – Jane Morrison-Ross, Chief Executive of South of Scotland Enterprise